Case Reports
doi: 10.1016/0165-1781(79)90006-4.
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues
- PMID: 298352
- DOI: 10.1016/0165-1781(79)90006-4
Item in Clipboard
Case Reports
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues
Psychiatry Res.
1979 Dec.
Abstract
Abuse of 4-propyloxy-4-phenyl-N-methylpiperidine, a meperidine congener, produced parkinsonism in a 23-year-old man. Unlike other drug-induced motor disturbances, the syndrome persisted for 18 months and responded to drugs that stimulate dopamine receptors. Biogenic amines and metabolites in the cerebrospinal fluid and microscopic evaluation of the brain at necropsy were consistent with damage to aminergic neurons in the substantia nigra.
Similar articles
-
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.Science. 1983 Feb 25;219(4587):979-80. doi: 10.1126/science.6823561. Science. 1983. PMID: 6823561
-
Parkinsonism from methanol poisoning: benefit from treatment with anti-Parkinson drugs.Mov Disord. 1999 May;14(3):520-2. doi: 10.1002/1531-8257(199905)14:3<520::aid-mds1026>3.0.co;2-v. Mov Disord. 1999. PMID: 10348484 No abstract available.
-
Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year period.Mov Disord. 1986;1(1):65-8. doi: 10.1002/mds.870010109. Mov Disord. 1986. PMID: 3504233
-
[Significance of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine for the etiology and therapy of idiopathic Parkinson disease].Fortschr Neurol Psychiatr. 1989 Apr;57(4):142-8. doi: 10.1055/s-2007-1000755. Fortschr Neurol Psychiatr. 1989. PMID: 2656447 Review. German.
-
Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.Mov Disord. 1995 Jul;10(4):489-95. doi: 10.1002/mds.870100414. Mov Disord. 1995. PMID: 7565831 Review.
Cited by
-
Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson's Disease.Antioxidants (Basel). 2020 Oct 16;9(10):1007. doi: 10.3390/antiox9101007. Antioxidants (Basel). 2020. PMID: 33081318 Free PMC article. Review.
-
Poor hydroxylator phenotypes of debrisoquine and S-mephenytoin are not over-represented in a group of patients with Parkinson's disease.Br J Clin Pharmacol. 1990 Aug;30(2):301-2. doi: 10.1111/j.1365-2125.1990.tb03780.x. Br J Clin Pharmacol. 1990. PMID: 2206793 Free PMC article. No abstract available.
-
Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity.Proc Natl Acad Sci U S A. 1987 May;84(10):3521-5. doi: 10.1073/pnas.84.10.3521. Proc Natl Acad Sci U S A. 1987. PMID: 3495000 Free PMC article.
-
Characterization and localization of cytochrome P450 mediated metabolism of MPTP to nor-MPTP in mouse brain: relevance to Parkinson's disease.Neurotox Res. 2001 Aug;3(4):369-80. doi: 10.1007/BF03033198. Neurotox Res. 2001. PMID: 14715467
-
Milestones in research on the pathophysiology of Parkinson's disease.Mov Disord. 2011 May;26(6):1032-41. doi: 10.1002/mds.23695. Mov Disord. 2011. PMID: 21626548 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
